Display options
Cite
Marelli A. Trajectories of care in congenital heart disease - the long arm of disease in the womb. J Intern Med. 2020;288(4):390-399doi: 10.1111/joim.13048.
Marelli, A. (2020). Trajectories of care in congenital heart disease - the long arm of disease in the womb. Journal of internal medicine, 288(4), 390-399. https://doi.org/10.1111/joim.13048
Marelli, A. "Trajectories of care in congenital heart disease - the long arm of disease in the womb." Journal of internal medicine vol. 288,4 (2020): 390-399. doi: https://doi.org/10.1111/joim.13048
Marelli A. Trajectories of care in congenital heart disease - the long arm of disease in the womb. J Intern Med. 2020 Oct;288(4):390-399. doi: 10.1111/joim.13048. Epub 2020 Apr 22. PMID: 32323405.
Copy Download .nbib Format: NLM
Share it on

J Intern Med. 2020 Oct;288(4):390-399. doi: 10.1111/joim.13048. Epub 2020 Apr 22.

Trajectories of care in congenital heart disease - the long arm of disease in the womb.

Journal of internal medicine

A Marelli

Affiliations

  1. McGill University Health Centre, RVH/Glen Site, Cardiology, McGill University Health Centre, Montreal, Québec, Canada.

PMID: 32323405 DOI: 10.1111/joim.13048

Abstract

Our understanding of the development of congenital heart disease (CHD) across the lifespan has evolved. These include the evidence for the change in demographics of CHD, the observations that lifelong complications of CHD result in CHD as a lifespan disease, and the concept of long windows of exposure to risk that start in foetal life and magnify the expression of risk in adulthood. These observations set the stage for trajectories as an emerging construct to target health-service interventions. The lifelong cardiovascular and systemic complications of CHD make the long-term care of these patients challenging for cardiologists and internists alike. A life-course approach is thus required to facilitate our understanding of the natural history and to orient our clinical efforts. Three specific examples are illustrated: neurocognition; cancer resulting from exposure to low-dose ionizing radiation; and cardiovascular disease acquired in ageing adults. As patients grow, they do not just want to live longer, they want to live well. With the need to move beyond the mortality outcome, a shift in paradigm is needed. A life-course health development framework is developed for CHD. Trajectories are used as a complex construct to illustrate the patient's healthcare journey. There is a need to define disease trajectories, wellness trajectories and ageing trajectories in this population. Disease trajectories for repaired tetralogy of Fallot, transposition of the great arteries and the Fontan operation are hypothetically constructed. For clinicians, the life-course horizon helps to frame the patient's history and plan for the future. For researchers, life-course epidemiology offers a framework that will help increase the relevance of clinical enquiry and improve study design and analyses. A health-service policy framework is proposed for a growing number of conditions that start in the before birth and extend as long as contemporary survival now permits. Ultimately, the goal is the precision delivery of health services that enables lifelong health management, organization of developmental health services, and integration of vertical and horizontal health-service delivery.

© 2020 The Association for the Publication of the Journal of Internal Medicine.

Keywords: cardiology; congenital heart disease

References

  1. Marelli AJ, Mackie AS, Ionescu-Ittu R, Rahme E, Pilote L. Congenital heart disease in the general population: changing prevalence and age distribution. Circulation 2007; 115: 163-72. - PubMed
  2. Marelli AJ, Ionescu-Ittu R, Mackie AS, Guo L, Dendukuri N, Kaouache M. Lifetime prevalence of congenital heart disease in the general population from 2000 to 2010. Circulation 2014; 130: 749-756. - PubMed
  3. Afilalo J, Therrien J, Pilote L, Ionescu-Ittu R, Martucci G, Marelli AJ. Geriatric congenital heart disease burden of disease and predictors of mortality. J Am Coll Cardiol 2011; 58: 1509-15. - PubMed
  4. Gilboa SM, Devine OJ, Kucik JE et al. Congenital heart defects in the United States: estimating the magnitude of the affected population in 2010. Circulation 2016; 134: 101-9. - PubMed
  5. Dolk H, Loane M, Garne E. Congenital heart defects in Europe: prevalence and perinatal mortality, 2000 to 2005. Circulation 2011; 123: 841-9. - PubMed
  6. Moons P, Bovijn L, Budts W, Belmans A, Gewillig M. Temporal trends in survival to adulthood among patients born with congenital heart disease from 1970 to 1992 in Belgium. Circulation 2010; 122: 2264-72. - PubMed
  7. Marelli A, Miller SP, Marino BS, Jefferson AL, Newburger JW. Brain in congenital heart disease across the lifespan: the cumulative burden of injury. Circulation 2016; 133: 1951-62. - PubMed
  8. Donofrio M. The heart-brain interaction in the fetus: Cerebrovascular blood flow in the developing human. Progress Pediatric Cardiol 2006; 22: 41-51. - PubMed
  9. Glauser TA, Rorke LB, Weinberg PM, Clancy RR. Congenital brain anomalies associated with the hypoplastic left heart syndrome. Pediatrics 1990; 85: 984-90. - PubMed
  10. Dimitropoulos A, McQuillen PS, Sethi V et al. Brain injury and development in newborns with critical congenital heart disease. Neurology 2013; 81: 241-8. - PubMed
  11. McQuillen PS, Goff DA, Licht DJ. Effects of congenital heart disease on brain development. Prog Pediatr Cardiol 2010; 29: 79-85. - PubMed
  12. Jefferson AL, Himali JJ, Beiser AS et al. Cardiac index is associated with brain aging: the Framingham Heart Study. Circulation 2010; 122: 690-7. - PubMed
  13. Lanz J, Brophy JM, Therrien J, Kaouache M, Guo L, Marelli AJ. Stroke in adults with congenital heart disease: incidence, cumulative risk, and predictors. Circulation 2015; 132: 2385-94. - PubMed
  14. Bagge CN, Henderson VW, Laursen HB, Adelborg K, Olsen M, Madsen NL. Risk of dementia in adults with congenital heart disease: population-based cohort study. Circulation 2018; 137: 1912-1920. - PubMed
  15. Beausejour Ladouceur V, Lawler PR, Gurvitz M et al. Exposure to low-dose ionizing radiation from cardiac procedures in patients with congenital heart disease: 15-year data from a population-based longitudinal cohort. Circulation 2016; 133: 12-20. - PubMed
  16. Ait-Ali L, Andreassi MG, Foffa I, Spadoni I, Vano E, Picano E. Cumulative patient effective dose and acute radiation-induced chromosomal DNA damage in children with congenital heart disease. Heart 2010; 96: 269-74. - PubMed
  17. Johnson JN, Hornik CP, Li JS et al. Cumulative radiation exposure and cancer risk estimation in children with heart disease. Circulation 2014; 130: 161-7. - PubMed
  18. Glatz AC, Purrington KS, Klinger A et al. Cumulative exposure to medical radiation for children requiring surgery for congenital heart disease. J Pediatr 2014; 164: 789-94.e10. - PubMed
  19. Cohen S, Liu A, Gurvitz M et al. Exposure to low-dose ionizing radiation from cardiac procedures and malignancy risk in adults with congenital heart disease. Circulation 2018; 137: 1334-45. - PubMed
  20. Daniels CJ, Bradley EA, Landzberg MJ et al. Fontan-associated liver disease: proceedings from the American College of Cardiology Stakeholders Meeting, October 1 to 2, 2015, Washington DC. J Am Coll Cardiol 2017; 70: 3173-94. - PubMed
  21. Bouchardy J, Therrien J, Pilote L et al. Atrial arrhythmias in adults with congenital heart disease. Circulation 2009; 120: 1679-86. - PubMed
  22. Lowe BS, Therrien J, Ionescu-Ittu R, Pilote L, Martucci G, Marelli AJ. Diagnosis of pulmonary hypertension in the congenital heart disease adult population impact on outcomes. J Am Coll Cardiol 2011; 58: 538-46. - PubMed
  23. Roifman I, Therrien J, Ionescu-Ittu R et al. Coarctation of the aorta and coronary artery disease: fact or fiction? Circulation 2012; 126: 16-21. - PubMed
  24. Verheugt CL, Uiterwaal CS, van der Velde ET et al. Mortality in adult congenital heart disease. Eur Heart J 2010; 31: 1220-9. - PubMed
  25. Van den Bosch AE, Roos-Hesselink JW, Van Domburg R, Bogers AJ, Simoons ML, Meijboom FJ. Long-term outcome and quality of life in adult patients after the Fontan operation. Am J Cardiol 2004; 93: 1141-5. - PubMed
  26. Billett J, Cowie MR, Gatzoulis MA, Vonder Muhll IF, Majeed A. Comorbidity, healthcare utilisation and process of care measures in patients with congenital heart disease in the UK: cross-sectional, population-based study with case-control analysis. Heart 2008; 94: 1194-9. - PubMed
  27. Kirklin JW, Blackstone EH, Tchervenkov CI, Castaneda AR. Clinical outcomes after the arterial switch operation for transposition. Patient, support, procedural, and institutional risk factors. Congenital Heart Surgeons Society. Circulation 1992; 86: 1501-15. - PubMed
  28. Webb G, Mulder BJ, Aboulhosn J et al. The care of adults with congenital heart disease across the globe: Current assessment and future perspective: A position statement from the International Society for Adult Congenital Heart Disease (ISACHD). Int J Cardiol 2015; 195: 326-33. - PubMed
  29. Khairy P, Ionescu-Ittu R, Mackie AS, Abrahamowicz M, Pilote L, Marelli AJ. Changing mortality in congenital heart disease. J Am Coll Cardiol 2010; 56: 1149-57. - PubMed
  30. Connelly M, Webb G, Somerville J et al. Canadian consensus conference on adult congenital heart disease 1996. Canadian J Cardiol 1998; 14: 395-452. - PubMed
  31. Webb GD, Williams RG. Care of the adult with congenital heart disease: introduction. J Am Coll Cardiol 2001; 37: 1166. - PubMed
  32. Mylotte D, Pilote L, Ionescu-Ittu R et al. Specialized adult congenital heart disease care: the impact of policy on mortality. Circulation 2014; 129: 1804-12. - PubMed
  33. Gurvitz M, Marelli A, Mangione-Smith R, Jenkins K. Building quality indicators to improve care for adults with congenital heart disease. J Am Coll Cardiol 2013; 62: 2244-53. - PubMed
  34. Chowdhury D, Gurvitz M, Marelli A et al. American college of cardiology’s adult C and pediatric cardiology section’s ambulatory pediatric cardiology quality metrics working g. development of quality metrics in ambulatory pediatric, cardiology. J Am Coll Cardiol 2017; 69: 541-555. - PubMed
  35. Cohen S, Marelli A. Increasing survival in patients with congenital heart disease-a glass half full or half empty? JAMA Intern Med 2017; 177: 1690-1. - PubMed
  36. Mandalenakis Z, Rosengren A, Skoglund K, Lappas G, Eriksson P, Dellborg M. Survivorship in children and young adults with congenital heart disease in Sweden. JAMA Intern Med 2017; 177: 224-230. - PubMed
  37. Halfon N, Hochstein M. Life course health development: an integrated framework for developing health, policy, and research. Milbank Q 2002; 80: 433-479, iii. - PubMed
  38. Kuh D, Ben-Shlomo Y, Lynch J, Hallqvist J, Power C. Life course epidemiology. J Epidemiol Community Health 2003; 57: 778-83. - PubMed
  39. Thanassoulis G, Pencina MJ, Sniderman AD. The benefit model for prevention of cardiovascular disease: an opportunity to harmonize guidelines. JAMA Cardiol 2017; 2: 1175-6. - PubMed
  40. Ben-Shlomo Y, Kuh D. A life course approach to chronic disease epidemiology: conceptual models, empirical challenges and interdisciplinary perspectives. Int J Epidemiol 2002; 31: 285-93. - PubMed
  41. Ben-Shlomo Y, Cooper R, Kuh D. The last two decades of life course epidemiology, and its relevance for research on ageing. Int J Epidemiol 2016; 45: 973-88. - PubMed
  42. Pakpahan E, Hoffmann R, Kroger H. The long arm of childhood circumstances on health in old age: Evidence from SHARELIFE. Adv Life Course Res 2017; 31: 1-10. - PubMed
  43. Belle A, Thiagarajan R, Soroushmehr SM, Navidi F, Beard DA, Najarian K. Big data analytics in healthcare. Biomed Res Int 2015; 2015: 370194. - PubMed
  44. Obermeyer Z, Emanuel EJ. Predicting the future - big data, machine learning, and clinical medicine. N Engl J Med 2016; 375: 1216-9. - PubMed
  45. Alaa AM, Bolton T, Di Angelantonio E, Rudd JHF, van der Schaar M. Cardiovascular disease risk prediction using automated machine learning: A prospective study of 423,604 UK Biobank participants. PLoS One 2019; 14: e0213653. - PubMed
  46. Weinberg CR, McElhinney DB. Pulmonary valve replacement in tetralogy of Fallot. Circulation 2014; 130: 795-8. - PubMed
  47. Wald RM, Valente AM, Marelli A. Heart failure in adult congenital heart disease: Emerging concepts with a focus on tetralogy of Fallot. Trends Cardiovasc Med 2015; 25: 422-32. - PubMed
  48. Khairy P, Aboulhosn J, Gurvitz MZ et al. Arrhythmia burden in adults with surgically repaired tetralogy of Fallot: a multi-institutional study. Circulation 2010; 122: 868-75. - PubMed
  49. Burkhart HM, Dearani JA, Mair DD et al. The modified Fontan procedure: early and late results in 132 adult patients. J Thorac Cardiovasc Surg 2003; 125: 1252-9. - PubMed
  50. Gewillig M. The Fontan circulation. Heart 2005; 91: 839-46. - PubMed
  51. Anderson PA, Sleeper LA, Mahony L et al. 3rd and Pediatric Heart Network I. Contemporary outcomes after the Fontan procedure: a Pediatric Heart Network multicenter study. J Am Coll Cardiol 2008; 52: 85-98. - PubMed
  52. Khairy P, Fernandes SM, Mayer JE Jr et al. Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation 2008; 117: 85-92. - PubMed
  53. Marelli A. Four decades of the Fontan operation: did we ever have a leg to stand on? J Am Coll Cardiol 2010; 56: 151-3. - PubMed
  54. Lunney JR, Lynn J, Hogan C. Profiles of older medicare decedents. J Am Geriatr Soc 2002; 50: 1108-12. - PubMed
  55. d’Udekem Y, Iyengar AJ, Galati JC et al. Redefining expectations of long-term survival after the Fontan procedure: twenty-five years of follow-up from the entire population of Australia and New Zealand. Circulation 2014; 130: S32-8. - PubMed
  56. Senning Å. Surgical correction of transposition of the great vessels. Surgery. 1959; 45: 966-975. - PubMed
  57. Mustard WT. Successful two-stage correction of transposition of the great vessels. Surgery 1964; 55: 469-73. - PubMed
  58. Castaneda AR, Norwood WI, Lang P. Transposition of the great arteries and intact ventricular septum: Anatomical repair in the neonate. Annals Thoracic Surgery 1984; 38: 438-43. - PubMed
  59. Mee RBB. Severe right ventricular failure after Mustard or Senning operation. J Thoracic Cardiovascular Surgery 1986; 92: 385-90. - PubMed
  60. Chang AC, Wernovsky G, Wessel DL et al. Surgical management of late right ventricular failure after Mustard or Senning repair. Circulation 1992; 86: II-140-9. - PubMed
  61. Gelatt M, Hamilton RM, McCrindle BW et al. Arrhythmia and mortality after the Mustard procedure: a 30-year single-center experience. J Am Coll Cardiol 1997; 29: 194-201. - PubMed
  62. Flinn CJ, Wolff GS, Dick M 2nd et al. Cardiac rhythm after the Mustard operation for complete transposition of the great arteries. N Engl J Med 1984; 310: 1635-8. - PubMed
  63. Khairy P, Clair M, Fernandes SM et al. Cardiovascular outcomes after the arterial switch operation for D-transposition of the great arteries. Circulation 2013; 127: 331-9. - PubMed

MeSH terms

Publication Types

Grant support